Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Agilon Health (AGL) Accumulated Depreciation & Amortization (2020 - 2025)

Agilon Health's Accumulated Depreciation & Amortization history spans 6 years, with the latest figure at $28.6 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 16.89% year-over-year to $28.6 million; the TTM value through Dec 2025 reached $28.6 million, up 16.89%, while the annual FY2025 figure was $28.6 million, 16.89% up from the prior year.
  • Accumulated Depreciation & Amortization reached $28.6 million in Q4 2025 per AGL's latest filing, up from $24.5 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $28.6 million in Q4 2025 to a low of $13.8 million in Q4 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is $20.3 million, with a median of $20.2 million recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 101.65% in 2021, then decreased 6.12% in 2022.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $14.7 million in 2021, then dropped by 6.12% to $13.8 million in 2022, then skyrocketed by 46.39% to $20.2 million in 2023, then rose by 21.34% to $24.5 million in 2024, then increased by 16.89% to $28.6 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Accumulated Depreciation & Amortization are $28.6 million (Q4 2025), $24.5 million (Q4 2024), and $20.2 million (Q4 2023).